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Pyoderma gangrenosum (PG) is a rare neutrophilic dermatosis characterized by noninfectious, inﬂammatory, ulcerating
lesions. Pathergy can be seen in these patients, whereby minor trauma or surgery can result in the development of PG
ulcerations. Here, we present a case of PG following pacemaker implantation. A 76-year-old male with a history of
rheumatoid arthritis presented to the cardiology team with symptomatic bradycardia. Indications for implantation were
met, and the procedure was performed in a routine fashion. The patient returned to clinic for follow-up four days later,
complaining of pain at the incision site, coupled with erythema and purulent drainage. Consultations with an infectious
disease specialist and a dermatologist were requested, and the diagnosis of pyoderma gangrenosum was considered. The
patient underwent device removal and received systemic corticosteroids at a dose of 1 mg/kg prednisone with complete
lesion healing in 3 weeks. While being maintained on steroids, the patient underwent reimplantation of a new pacemaker
on the contralateral side without complication and had a normal postoperative course. We present this case report, along
with the review of literature, in order to highlight the multidisciplinary approach to management, which requires
dermatologic treatment in order to achieve pacemaker success.

1. Introduction
Pyoderma gangrenosum (PG) is a rare neutrophilic dermatosis characterized by noninfectious, inﬂammatory, ulcerating
lesions [1]. Lesions occur most commonly on the lower legs,
but any part of the skin can be involved. The most common
age of presentation is between 40 and 60 years, with less
common cases occurring in children or older adults [1, 2].
While the exact etiology is unknown, the neutrophilic reaction is hypothesized to occur due to the interplay between
neutrophilic dysfunction, genetic risk factors, and systemic
inﬂammation. Ulcerative colitis, Crohn’s disease, rheumatoid
arthritis, and chronic active hepatitis are commonly involved
inﬂammatory disorders [1]. Pathergy can be seen in these
patients, whereby minor trauma or surgery can result in the
development of PG ulcerations [1].

Here, we present a case of PG following pacemaker
implantation in a patient with rheumatoid arthritis. This rare
complication has only been reported in the literature in 6
cases [3–8]. We will be presenting our case as well as reviewing the literature in order to characterize cases of PG complicating pacemaker implantation and how dermatologic and
cardiac conditions were concomitantly managed.

2. Case Report
A 76-year-old male with a history of rheumatoid arthritis
presented to the cardiology team with symptomatic bradycardia. Indications for implantation of a dual-chamber pacing system were met, and the procedure was performed in a
routine fashion in the left prepectoral area by the cardiac
electrophysiologist. Standard postoperative precautions were
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Figure 1: Purulent ulcer with dusky, violaceous borders on a
background of erythema.

Figure 2: Healing ulcer with black central crusting and a rim of
erythema.

taken, and the patient was discharged uneventfully the following day. A course of prophylactic antibiotics was prescribed, consisting of doxycycline 100 mg PO twice daily.
The patient returned to the pacemaker clinic for followup four days later, complaining of pain at the incision site,
coupled with erythema and purulent drainage (Figure 1).
Signs and symptoms were suspicious for a pocket infection,
and the patient was admitted for parenteral antibiotics (vancomycin and piperacillin/tazobactam) and scheduled for
device removal. A complete blood count (CBC) revealed a
mildly elevated white blood cell count (10:9 × 103 /microliter) and a neutrophil count within normal limits. Swabs of
the purulent material in the pacemaker pocket at the time
of device explantation were sent for aerobic and anaerobic
cultures and were negative for bacterial growth. Three sets
of blood cultures were also negative.
Consultations with an infectious disease specialist and a
dermatologist were requested, and the diagnosis of pyoderma
gangrenosum was strongly considered. Skin biopsy was performed, revealing massive neutrophilic inﬁltration and
necrosis consistent with pyoderma gangrenosum. The
patient underwent device removal and received systemic corticosteroids at a dose of 1 mg/kg prednisone with complete
lesion healing in 3 weeks (Figure 2). While being maintained
on steroids, the patient underwent reimplantation of a new
pacemaker on the contralateral side without complication
and had a normal postoperative course. Steroids were then
tapered gradually over 3 months with no recurrence of disease 1 year later.

Diagnosis of PG is often diﬃcult to make, given the
nonspeciﬁc clinical and histopathological manifestations.
Clinical ﬁndings may mimic primary cutaneous infection,
vasculitis, drug-induced tissue injury, or other inﬂammatory disorders [1]. Biopsy often reveals nonspeciﬁc ﬁndings
that can include granulomatous dermatitis, folliculitis, and
leukocytoclastic vasculitis [1]. Workup for underlying etiologies of PG should be considered. This includes CBC,
erythrocyte sedimentation rate (ESR), liver function tests
(LFTs), protein electrophoresis, antineutrophil cytoplasmic
antibodies (ANCA), and cryoglobulins [1]. In many cases,
an underlying etiology is not found.
The ﬁrst-line treatment of PG is systemic corticosteroids (0.5-2.0 mg/kg/day), along with local wound management [1, 8]. Addition of oral cyclosporine to systemic
steroids may be required when initial disease is severe
[1]. Mycophenolate mofetil, cyclophosphamide, chlorambucil, and azathioprine have also been eﬀective in
corticosteroid-resistant cases [1, 11]. Once systemic corticosteroid is tapered, maintenance with immunosuppressant
agents can be considered. Commonly used immunosuppressants are cyclosporine and antitumor necrosis factor (TNF)
agents, which include inﬂiximab and etanercept [8].
Presentation of PG following pacemaker implantation
has been reported in 6 cases, 4 of which were initially managed as infectious complications and treated with antibiotics
(Table 1). Following continued necrosis and ulceration,
further workup revealed a diagnosis of pyoderma gangrenosum. In all cases, systemic corticosteroids resulted in local
improvement of PG ulcers. In some of the cases, reimplantation of the pacemaker with the use of cyclosporine allowed
cardiologists to manage the cardiac condition while preventing recurrence of PG.
We present this case report, along with the review of literature, in order to highlight the multidisciplinary approach
to management, which requires dermatologic treatment in
order to achieve pacemaker success. Given the rare nature
of the complication, cardiologists are unlikely to encounter
it in practice. However, when it does occur, it is likely that
an infectious nature be the highest on the list of diﬀerential
diagnoses simply due to the clinical presentation. Nevertheless, it is important for cardiologists to consider PG and have
a lower threshold for a dermatologic consult or biopsy in
cases where antibiotics have been ineﬀective. This can prevent delayed diagnosis, reducing the risk of more severe

3. Discussion
PG has been associated with systemic inﬂammation,
surgery, or minor trauma. However, most cases are of
unknown etiology. PG lesions often begin as tender,
inﬂammatory papules or pustules with an indurated, dusky
red peripheral rim [1]. As necrosis ensues, an ulcer forms
a pustular base with a violaceous border. Less commonly,
PG can present with bullous, vegetative, or pustular predominance [9]. Postoperative PG can be seen following
surgery, whereby ulcers present at the surgical site within
2 weeks following the operation [10]. This presents as
severe pain out of proportion to physical exam along with
erythema and wound dehiscence [10].

Postoperative day 7

15 months following
pacemaker implantation

Postoperative day 4

Postoperative day 4

70 F with monoclonal
gammopathy, diabetes, and
2 : 1 atrioventricular block

64 M with second-degree
heart block

72 M with 2 : 1
atrioventricular block

76 M with rheumatoid
arthritis

Cosio et al. [6], 2006

Duncan et al. [7], 2009

Marzak et al. [8], 2019

Ayoubi et al., 2019

Red, indurated, and
partially open ulcer at the
site of implant

3 weeks following
pacemaker implantation

71 F with syncope

Patient was started on antibiotics and pacemaker was
removed. Two more trials of pacemaker insertion were
done with continued ulceration in both cases. Topical
steroids were ineﬀective. Prednisolone (20 mg/day) for
10 days resulted in improvement. Remained
well-controlled on cyclosporine for two
months without recurrence.

Kaur et al. [5], 2006

Steroid therapy resulted in improvement and
abdominal implant was considered instead.

Not discussed

Recurrent skin lesions at the
site of pacemaker implantation
in the upper thorax

71 M

Gebska et al. [4], 2005

Not discussed

Outcome

Initial treatment with antibiotics led to
continued necrosis; local healing occurred with
systemic corticosteroids. On postoperative day 45,
patient developed septic shock secondary
to infection of prior PG lesion. Removal and
reimplantation of new pacemaker were done.
IV inﬂiximab (5 mg/kg), colchicine (1 mg/day),
corticosteroids (1 mg/kg), and antibiotics were
prophylactically given. One-year follow-up was uneventful.

Unrelated trauma to the
implant site led to cystic swelling
and subsequent ulceration

Inﬂammatory, inﬁltrative,
necrotic ulcer at the
implant site

Pain at the incision site, coupled
with erythema and purulent drainage

Pacemaker broke down following ulceration.
Antibiotics failed to beneﬁt. Prednisolone (60 mg/day)
led to improvement. This was followed by recurrence
after steroids taper. Restarting prednisolone with
cyclosporine (3 mg/kg) led to complete healing.
Patient remained controlled on cyclosporine.

Initial treatment with antibiotics was ineﬀective.
Swabs of purulent material revealed negative
cultures for bacterial growth. Systemic prednisone
(1 mg/kg) resulted in complete healing in 3 weeks.
Steroid maintenance allowed for reimplantation of
new pacemaker without complications.

Prednisone (60 mg daily) led to healing within 3 weeks.
Patient developed concomitant heart failure and nephrotic
syndrome, which led to death 1 month following admission.

Painful, necrotic lesion at
the implant site

Initial treatment as infection led to
pacemaker extraction; healing occurred with
systemic corticosteroids.

Lo et al. [3], 2002

Presentation
Ulcer with erythematous
border on the left
anterior chest

Onset

Patient characteristics

85 F with monoclonal
gammopathy and
polymyalgia rheumatica

Author, year

Table 1: Pyoderma gangrenosum following pacemaker implantation.
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complications such as actual infection. Furthermore, prophylaxis against PG can allow for reimplantation of the pacemaker by cardiologists, allowing patients to receive the
requirement operation that prompted this condition in the
ﬁrst place.

Abbreviations
PG:
CBC:
ESR:
LFT:
ANCA:
TNF:

Pyoderma gangrenosum
Complete blood count
Erythrocyte sedimentation rate
Liver function tests
Antineutrophil cytoplasmic antibodies
Tumor necrosis factor.
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